Real-world experience of anifrolumab in 30 patients with refractory dermatomyositis: a multicenter-multidisciplinary retrospective study
Rheumatology (Oxford). 2025 Dec 16:keaf662. doi: 10.1093/rheumatology/keaf662. Online ahead of print. ABSTRACT OBJECTIVE: To assess real-world outcomes of anifrolumab (ANI) […]



